Sampath Anand
EVP, Ops & Clinical Research at MASIMO CORP
- Sold, on record
- $36.6M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Jan 28, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MASIMO CORPEVP, Ops & Clinical Research
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MASIMO CORPUnusualJul 11, 2017 2017
Sold 40,000 shares at $92.00 ($3.7M)
Sampath Anand, Chief Operating Officer
Sold 80% of holdings ($4.6M position)10,000 shares leftFiling
- 2 Form 4 sale MASIMO CORPUnusualNov 28, 2018 +505 days
Sold 30,000 shares at $110.00 ($3.3M)
Sampath Anand, Chief Operating Officer
Sold 72.7% of holdings ($4.5M position)11,272 shares leftFiling
- 3 Form 4 sale MASIMO CORPUnusualJan 15, 2019 +48 days
Sold 30,000 shares at $115.00 ($3.5M)
Sampath Anand, Chief Operating Officer
Sold 70.6% of holdings ($4.9M position)12,518 shares leftFiling
- 4 Form 4 sale MASIMO CORPUnusualJun 14, 2019 +150 days
Sold 30,000 shares at $142.39 ($4.3M)
Sampath Anand, EVP, Ops & Clinical Research
Sold 70.6% of holdings ($6.1M position)12,518 shares left1x usual sizeFiling
- 5 Form 4 sale MASIMO CORPUnusualNov 20, 2019 +159 days
Sold 15,000 shares at $155.00 ($2.3M)
Sampath Anand, EVP, Ops & Clinical Research
Sold 54.5% of holdings ($4.3M position)12,518 shares left0.5x usual sizeFiling
- 6 Form 4 sale MASIMO CORPUnusualApr 13, 2020 +145 days
Sold 19,796 shares at $180.00 ($3.6M)
Sampath Anand, EVP, Ops & Clinical Research
Sold 59% of holdings ($6M position)13,782 shares left0.7x usual sizeFiling
- 7 Form 4 sale MASIMO CORPUnusualDec 15, 2020 +246 days
Sold 30,000 shares at $265.60 ($8M)
Sampath Anand, EVP, Ops & Clinical Research
Sold 68.5% of holdings ($11.6M position)13,782 shares left1.2x usual sizeFiling
- 8 Form 4 sale MASIMO CORPUnusualJan 28, 2026 +1870 days
Sold 18,680 shares at $136.81 ($2.6M)
Sampath Anand, EVP, Ops & Clinical Research
No 10b5-1 planSold 31.3% of holdings ($8.2M position)40,909 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Jan 30, 2026 | MASIMO CORP | EVP, Ops & Clinical Research | Form 4 sale | 18,680 | $2.6M | 31.3% | Unusual | SEC |
| Dec 15, 2020 | Dec 17, 2020 | MASIMO CORP | EVP, Ops & Clinical Research | Form 4 sale | 30,000 | $8M | 68.5% | Unusual | SEC |
| Apr 13, 2020 | Apr 15, 2020 | MASIMO CORP | EVP, Ops & Clinical Research | Form 4 sale | 19,796 | $3.6M | 59.0% | Unusual | SEC |
| Nov 20, 2019 | Nov 21, 2019 | MASIMO CORP | EVP, Ops & Clinical Research | Form 4 sale | 15,000 | $2.3M | 54.5% | Unusual | SEC |
| Jun 14, 2019 | Jun 18, 2019 | MASIMO CORP | EVP, Ops & Clinical Research | Form 4 sale | 30,000 | $4.3M | 70.6% | Unusual | SEC |
| Jan 15, 2019 | Jan 16, 2019 | MASIMO CORP | Chief Operating Officer | Form 4 sale | 30,000 | $3.5M | 70.6% | Unusual | SEC |
| Nov 28, 2018 | Nov 30, 2018 | MASIMO CORP | Chief Operating Officer | Form 4 sale | 30,000 | $3.3M | 72.7% | Unusual | SEC |
| Jul 11, 2017 | Jul 13, 2017 | MASIMO CORP | Chief Operating Officer | Form 4 sale | 40,000 | $3.7M | 80.0% | Unusual | SEC |
| Nov 1, 2016 | Nov 2, 2016 | MASIMO CORP | Chief Operating Officer | Form 4 sale | 65,000 | $3.6M | 100.0% | Unusual | SEC |
| Nov 6, 2015 | Nov 10, 2015 | MASIMO CORP | Chief Operating Officer | Form 4 sale | 45,000 | $1.9M | 100.0% | Unusual | SEC |